Lisa Borges-Marcucci

473 total citations
9 papers, 403 citations indexed

About

Lisa Borges-Marcucci is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, Lisa Borges-Marcucci has authored 9 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Genetics and 4 papers in Cancer Research. Recurrent topics in Lisa Borges-Marcucci's work include Estrogen and related hormone effects (5 papers), Cytokine Signaling Pathways and Interactions (5 papers) and NF-κB Signaling Pathways (4 papers). Lisa Borges-Marcucci is often cited by papers focused on Estrogen and related hormone effects (5 papers), Cytokine Signaling Pathways and Interactions (5 papers) and NF-κB Signaling Pathways (4 papers). Lisa Borges-Marcucci collaborates with scholars based in Canada and United States. Lisa Borges-Marcucci's co-authors include Douglas C. Harnish, Mark J. Evans, Christopher C. Chadwick, James C. Keith, Robert J. Steffan, Eugene J. Trybulski, A Eckert, Edward Matelan, Susan Chippari and Mark A. Ashwell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and American Journal of Physiology-Gastrointestinal and Liver Physiology.

In The Last Decade

Lisa Borges-Marcucci

9 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Borges-Marcucci Canada 8 172 111 98 85 67 9 403
Katsuyoshi Kawana Japan 8 125 0.7× 88 0.8× 139 1.4× 92 1.1× 49 0.7× 11 519
S. Theocharis Greece 10 97 0.6× 35 0.3× 314 3.2× 62 0.7× 56 0.8× 16 551
Wakashi Kitayama Japan 11 71 0.4× 156 1.4× 187 1.9× 68 0.8× 88 1.3× 18 547
Hameda B. Hussain United States 7 48 0.3× 62 0.6× 218 2.2× 114 1.3× 48 0.7× 7 470
Maheul Ploton France 10 166 1.0× 25 0.2× 256 2.6× 170 2.0× 124 1.9× 10 488
Labile Togba Soumaoro Japan 6 134 0.8× 83 0.7× 140 1.4× 51 0.6× 29 0.4× 7 405
Taku Kusaba Japan 6 74 0.4× 122 1.1× 96 1.0× 52 0.6× 59 0.9× 7 410
S. Skarosi United States 13 136 0.8× 102 0.9× 423 4.3× 88 1.0× 35 0.5× 16 690
S. Noura Japan 9 176 1.0× 52 0.5× 168 1.7× 131 1.5× 12 0.2× 14 452
Pablo Morentin Gutierrez United Kingdom 11 91 0.5× 32 0.3× 140 1.4× 16 0.2× 81 1.2× 22 402

Countries citing papers authored by Lisa Borges-Marcucci

Since Specialization
Citations

This map shows the geographic impact of Lisa Borges-Marcucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Borges-Marcucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Borges-Marcucci more than expected).

Fields of papers citing papers by Lisa Borges-Marcucci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Borges-Marcucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Borges-Marcucci. The network helps show where Lisa Borges-Marcucci may publish in the future.

Co-authorship network of co-authors of Lisa Borges-Marcucci

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Borges-Marcucci. A scholar is included among the top collaborators of Lisa Borges-Marcucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Borges-Marcucci. Lisa Borges-Marcucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lundquist, Joseph T., Douglas C. Harnish, John F. Mehlmann, et al.. (2010). Improvement of Physiochemical Properties of the Tetrahydroazepinoindole Series of Farnesoid X Receptor (FXR) Agonists: Beneficial Modulation of Lipids in Primates. Journal of Medicinal Chemistry. 53(4). 1774–1787. 42 indexed citations
2.
Evans, Mark J., Paige E. Mahaney, Lisa Borges-Marcucci, et al.. (2009). A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia. American Journal of Physiology-Gastrointestinal and Liver Physiology. 296(3). G543–G552. 79 indexed citations
3.
4.
Evans, Mark J., Paige E. Mahaney, Helen B. Hartman, et al.. (2007). PO4-97 ACTIVATION OF FARNESOID X RECEPTOR (FXR) PROTECTS AGAINST DIET-INDUCED DYSLIPIDEMIA. Atherosclerosis Supplements. 8(1). 41–41. 1 indexed citations
5.
Steffan, Robert J., Edward Matelan, Mark A. Ashwell, et al.. (2006). Control of Chronic Inflammation with Pathway Selective Estrogen Receptor Ligands. Current Topics in Medicinal Chemistry. 6(2). 103–111. 11 indexed citations
6.
Keith, James C., Leo Albert, Max Follettie, et al.. (2005). The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-κB transcriptional activity in models of rheumatoid arthritis. Arthritis Research & Therapy. 7(3). R427–38. 48 indexed citations
7.
Borges-Marcucci, Lisa, et al.. (2005). Bile acid signaling through FXR induces intracellular adhesion molecule-1 expression in mouse liver and human hepatocytes. American Journal of Physiology-Gastrointestinal and Liver Physiology. 289(2). G267–G273. 39 indexed citations
8.
Chadwick, Christopher C., Susan Chippari, Edward Matelan, et al.. (2005). Identification of pathway-selective estrogen receptor ligands that inhibit NF-κB transcriptional activity. Proceedings of the National Academy of Sciences. 102(7). 2543–2548. 112 indexed citations
9.
Steffan, Robert J., Edward Matelan, Mark A. Ashwell, et al.. (2004). Synthesis and Activity of Substituted 4-(Indazol-3-yl)phenols as Pathway-Selective Estrogen Receptor Ligands Useful in the Treatment of Rheumatoid Arthritis. Journal of Medicinal Chemistry. 47(26). 6435–6438. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuyoshi Kawana Breakdown of academic impact, for papers by S. Theocharis Breakdown of academic impact, for papers by Wakashi Kitayama Breakdown of academic impact, for papers by Hameda B. Hussain Breakdown of academic impact, for papers by Maheul Ploton Breakdown of academic impact, for papers by Labile Togba Soumaoro Breakdown of academic impact, for papers by Taku Kusaba Breakdown of academic impact, for papers by S. Skarosi Breakdown of academic impact, for papers by S. Noura Breakdown of academic impact, for papers by Pablo Morentin Gutierrez
Rankless by CCL
2026